Ohio State oncologist Ning Jin and colleagues are concerned by an increasing number of people in their 30s and 40s presenting with late-stage cancers of the lower digestive tract. These patients are developing tumors decades earlier than historic averages, and their cancers often respond poorly: even with aggressive chemotherapy or surgery, outcomes are not consistently better. Colorectal cancer is now the leading cancer killer for people under 50, while death rates have declined in older groups.
Genetics explain part of the rise—roughly 20% of early-onset cases carry hereditary risk markers such as mutations tied to Lynch syndrome—but most cases remain unexplained. That suggests environmental and lifestyle factors are driving the generational shift. Dr. John Marshall, head of clinical research at Georgetown’s Lombardi Cancer Center, says the change has been dramatic: when he began practicing more than 30 years ago he rarely saw patients under 50 with colon cancer; today they form a substantial portion of his clinic. He also notes tumors are appearing more often lower in the tract, nearer the rectum, a shift that points to recent changes in exposures or behavior.
Researchers are focusing on the gut microbiome—the community of bacteria and other microorganisms in the digestive tract—as a likely central factor. Increased consumption of ultra-processed foods, broader exposure to plastics and food-borne chemicals, and more sedentary lifestyles may alter the microbiome’s composition and function. Marshall compares the microbiome to soil: if that soil is changed, it affects how the body processes what we eat. Some chemicals and microbes may strip away the gut’s protective mucus layer, analogous to making holes in a fence, exposing tissue to chronic irritation and inflammation. Jin emphasizes that both microbes and environmental chemicals can contribute to DNA damage and to a leaky gut, processes that can promote tumor development.
Evidence is growing but complicated. Some studies have linked colibactin, a DNA-damaging toxin produced by certain E. coli strains, to colon cancer in younger patients. Yet the gut is not uniform: the mouth, stomach, small intestine and colon each host distinct microbial communities and chemistries, and local conditions may influence where tumors form. Clinicians also lack validated clinical tests to define a “healthy” microbiome or to predict when a microbial community is on a path toward cancer.
Investigators call for more controlled studies to identify which exposures and microbial changes drive early-onset colorectal cancer and when interventions might help. Meanwhile, doctors urge vigilance: greater attention to symptoms, careful consideration of family history, and wider access to earlier diagnostic testing for those at risk. Understanding how environmental and microbial factors combine will be critical to reversing this worrying trend among younger adults.